BIOTRONIK Launches First FDA Approved CRM Devices with MRI AutoDetect Technology
MRI AutoDetect Underscores the Importance of Extending Care Beyond the Implant
BIOTRONIK today announced the availability of the first FDA approved cardiac rhythm management (CRM) devices with technology that automatically recognizes when a patient enters an MRI environment. MRI AutoDetect is another example of BIOTRONIK’s commitment to helping physicians and hospitals care for patients beyond the implant.
BIOTRONIK’s MRI AutoDetect technology ensures patients with CRM devices can safely undergo MRI scans while minimizing programming burdens for hospitals. Once activated by a physician, MRI AutoDetect can automatically recognize when the patient enters an MRI environment and convert the device to MRI mode. When the scan is complete, MRI AutoDetect automatically returns the device to its permanent program. Physicians can program MRI AutoDetect to be active for up to 14 days, allowing patients unprecedented flexibility to undergo, reschedule or repeat MRI scans as needed during the set timeframe. MRI AutoDetect is currently available on BIOTRONIK’s newest line of CRM devices, including the Ilivia series for tachycardia.
BIOTRONIK is committed to encouraging discussions about the patient care continuum and will highlight proven CRM solutions at the Heart Rhythm Society’s 38th Annual Scientific Sessions on May 10-13 in Chicago (booth #820).
“At BIOTRONIK we know that physicians need trusted solutions that they can use with confidence. Because confidence provides peace of mind so physicians can focus on what is truly most important—patient care,” said Marlou Janssen, President of BIOTRONIK, Inc. “Patient care isn’t about one day, it’s about every single day. We must continue striving—as caregivers, as committed researchers, as industry partners—to provide care that extends beyond the implant. MRI AutoDetect is another example of innovative technology from BIOTRONIK that instills confidence and provides peace of mind for patients and caregivers.”
Attendees at the Heart Rhythm Scientific Sessions are invited to engage in the #CareBeyond discussion by participating in the following events:
1 Not currently available in the United States.
2 CAUTION – Investigational device. Limited by United States law to investigational use.
BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.